Tobias Merkle, PhDVice President Platform Development at AIRNASpeaker
Agenda Sessions
AIR-001: A Highly Potent and Precise GalNAc-conjugated RNA Base Editing Treatment for Alpha-1 Antitrypsin Deficiency
, 10:45View Session

